Notice of Intent to SS_1255752.pdf
PDF 141 KB Posted
- Attached to
- KingFisher Flex 96n Deep Well Instrument
- Solicitation number
- FDA-SS-1255752
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
FDA-SS-1255752
KingFisher Flex 96n Deep Well Instrument
Document Type: Notice of Intent to Sole Source Solicitation Number: FDA - Sole Source - 1255752 Posted Date: July 27, 2022 Response Date: August 5, 2022 NAICS Code: 334516 - Analytical Laboratory Instrument Manufacturing
The Food and Drug Administration (FDA) intends to award a Sole Source firm-fixed price purchase order to:
Life Technologies Corporation 3175 Staley Road Grand Island, NY 14072
In accordance with FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements.
TECHNICAL REQUIREMENTS:
1. Shall provide a newly manufactured, not used or refurbished or previously used for demonstration KingFisher Flex 96 Deep Well (DW).
2. Shall include a KingFisher Flex instrument with 96 DW head.
3. Shall include a SMARTSTART KF Flex, Mfr. Part Number: TRN00340.
4. Shall have the ability to process 1,000 µl sample in 96 wells format.
5. Shall be compatible with Applied Biosystems™ MagMAX™ kits and reagents.
This notice is not a request for competitive proposals. However, any party that believes it can meet this requirement as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement.
Capability statements must be received by the response date and time of this notice.
Submissions will be reviewed to determine if they can meet the requirement. A determination by the Government to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.
It is anticipated that an award will be issued to Life Technologies Corporation within approximately ten (10) days after the date of this notice unless the Government determines that any other organization has the capability to meet this requirement.
Response Date: August 5, 2022, by 4:00PM (EDT). Please email responses to Nicole Craig at nicole.craig@fda.hhs.gov. No phone calls will be accepted.
mailto:nicole.craig@fda.hhs.gov
File details come from the government source that posted it. Updated .